Verily has raised $300 million in new outside funding that ends parent company Alphabet's controlling position in the healthcare innovation company, according to Endpoints News. The funding round was led by Series X Capital.
The investment marks a significant shift in Verily's ownership structure, moving the company away from being a majority-controlled subsidiary of Google's parent company. This change could provide Verily with greater operational independence as it develops healthcare technologies and solutions.